DAVID MOATAZEDI, CEO & President, Director at Evolus, holds 533.35K shares in Evolus (Ticker: EOLS), holds 83.62K shares in ReShape Lifesciences (Ticker: RSLS), holds 0.00 shares in Biomerica (Ticker: BMRA).
What is the percentage of profitable transactions made by DAVID MOATAZEDI?
The percentage of profitable transactions made by DAVID MOATAZEDI is 57%.
What is the average return per transaction made by DAVID MOATAZEDI?
The average return per transaction made by DAVID MOATAZEDI is -4.90%.
What stocks does DAVID MOATAZEDI hold?
DAVID MOATAZEDI holds: EOLS, RSLS, BMRA stocks.
What was DAVID MOATAZEDI’s latest transaction?
DAVID MOATAZEDI latest transaction was an Uninformative Buy of $2.13M.
What was DAVID MOATAZEDI's most profitable transaction?
DAVID MOATAZEDI’s most profitable transaction was an Informative Sell of EOLS stock on May 18, 2022. The return on the trade was 19.70%.
What is DAVID MOATAZEDI's role in Evolus?
DAVID MOATAZEDI's role in Evolus is CEO & President, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.